Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation

BackgroundNumerous studies have demonstrated associations between genetic markers and COPD, but results have been inconsistent. One reason may be heterogeneity in disease definition. Unsupervised learning approaches may assist in understanding disease heterogeneity.MethodsWe selected 31 phenotypic variables and 12 SNPs from five candidate genes in 308 subjects in the National Emphysema Treatment Trial (NETT) Genetics Ancillary Study cohort. We used factor analysis to select a subset of phenotypic variables, and then used cluster analysis to identify subtypes of severe emphysema. We examined the phenotypic and genotypic characteristics of each cluster.ResultsWe identified six factors accounting for 75% of the shared variability among our initial phenotypic variables. We selected four phenotypic variables from these factors for cluster analysis: 1) post-bronchodilator FEV1 percent predicted, 2) percent bronchodilator responsiveness, and quantitative CT measurements of 3) apical emphysema and 4) airway wall thickness. K-means cluster analysis revealed four clusters, though separation between clusters was modest: 1) emphysema predominant, 2) bronchodilator responsive, with higher FEV1; 3) discordant, with a lower FEV1 despite less severe emphysema and lower airway wall thickness, and 4) airway predominant. Of the genotypes examined, membership in cluster 1 (emphysema-predominant) was associated with TGFB1 SNP rs1800470.ConclusionsCluster analysis may identify meaningful disease subtypes and/or groups of related phenotypic variables even in a highly selected group of severe emphysema subjects, and may be useful for genetic association studies.

[1]  C M Fletcher,et al.  The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. , 1966, Lancet.

[2]  V. Baranov,et al.  Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis , 1997, Human Genetics.

[3]  J. Bousquet,et al.  Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis , 1997 .

[4]  P. Hiemstra,et al.  Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .

[5]  P. Hiemstra,et al.  Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[6]  M. Tsukino,et al.  Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[7]  V. Sharma,et al.  Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage , 2000 .

[8]  M. Suthanthiran,et al.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Magnussen,et al.  Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[10]  J. Wedzicha The heterogeneity of chronic obstructive pulmonary disease , 2000, Thorax.

[11]  F. Yamasawa,et al.  Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). , 2001, American journal of respiratory and critical care medicine.

[12]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[13]  M. Selman,et al.  Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. , 2001, The European respiratory journal.

[14]  N. Anthonisen,et al.  Susceptibility genes for rapid decline of lung function in the lung health study. , 2001, American journal of respiratory and critical care medicine.

[15]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[16]  H. Shirasawa,et al.  Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. , 2002, Chest.

[17]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[18]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[19]  H. Kerstjens The GOLD classification has not advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.

[20]  B. Celli,et al.  Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.

[21]  D. Ruppert The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2004 .

[22]  Jan Stolk,et al.  Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[23]  Scott T. Weiss,et al.  The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) , 2004 .

[24]  S. Muro,et al.  Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. , 2004, Chest.

[25]  P. Calverley The GOLD classification has advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.

[26]  P. Paré,et al.  Glutathione S-transferase variants and their interaction with smoking on lung function. , 2004, American journal of respiratory and critical care medicine.

[27]  P. Black,et al.  Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. , 2004, Thorax.

[28]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[29]  H. Mal,et al.  Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. , 2005, Chest.

[30]  I. Pavord,et al.  Multi‐dimensional phenotyping: towards a new taxonomy for airway disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  N. Laird,et al.  Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. , 2005, American journal of respiratory cell and molecular biology.

[32]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  R. Mitchell Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance , 2006 .

[34]  E. Silverman,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[35]  B. Celli Chronic obstructive pulmonary disease phenotypes and their clinical relevance , 2006 .

[36]  Christoph Lange,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease. , 2006, American journal of human genetics.

[37]  D. DeMeo,et al.  Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[38]  A. Gulsvik,et al.  Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 , 2006, European Respiratory Journal.

[39]  E. Silverman Progress in chronic obstructive pulmonary disease genetics. , 2006, Proceedings of the American Thoracic Society.

[40]  B. Celli Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. , 2006, Proceedings of the American Thoracic Society.

[41]  M. Hasegawa,et al.  Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease , 2007, Thorax.

[42]  D. DeMeo,et al.  Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery , 2007, Respiratory research.

[43]  B. Make,et al.  Genetic determinants of emphysema distribution in the national emphysema treatment trial. , 2007, American journal of respiratory and critical care medicine.

[44]  Edwin K Silverman,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. , 2006, American journal of respiratory and critical care medicine.

[45]  Edwin K Silverman,et al.  Computed Tomography Phenotypes in Severe, Early-Onset Chronic Obstructive Pulmonary Disease , 2007, COPD.

[46]  Gianna Camiciottoli,et al.  Identification of a predominant COPD phenotype in clinical practice. , 2008, Respiratory medicine.

[47]  M. Ota,et al.  The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. , 2008, Internal medicine.

[48]  H. Ortega,et al.  Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[49]  G. Anderson,et al.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.

[50]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[51]  Eric A. Hoffman,et al.  Computed Tomographic-Based Quantification of Emphysema and Correlation to Pulmonary Function and Mechanics , 2008, COPD.

[52]  J. Reilly COPD and declining FEV1--time to divide and conquer? , 2008, The New England journal of medicine.

[53]  Siobhan M. Dolan,et al.  Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.

[54]  J. Vestbo,et al.  The many "small COPDs": COPD should be an orphan disease. , 2008, Chest.

[55]  Yasutaka Nakano,et al.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[56]  M. McInnis,et al.  Psychiatric genetics: progress amid controversy , 2008, Nature Reviews Genetics.

[57]  J. Seo,et al.  Quantitative Assessment of Emphysema, Air Trapping, and Airway Thickening on Computed Tomography , 2008, Lung.

[58]  E. Silverman,et al.  Polymorphic variation in surfactant protein B is associated with COPD exacerbations , 2008, European Respiratory Journal.

[59]  S Muro,et al.  Body mass index in male patients with COPD: correlation with low attenuation areas on CT , 2008, Thorax.

[60]  M. Pistolesi Beyond airflow limitation: another look at COPD , 2008, Thorax.

[61]  Dave Singh,et al.  COPD phenotype description using principal components analysis , 2009, Respiratory research.

[62]  M. Chan-yeung,et al.  Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease. , 2009, Respiratory medicine.

[63]  Gianna Camiciottoli,et al.  Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes , 2009, J. Biomed. Informatics.

[64]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[65]  Raúl San José Estépar,et al.  CT metrics of airway disease and emphysema in severe COPD. , 2009, Chest.

[66]  Byron C. Wallace,et al.  The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. , 2009, Human molecular genetics.

[67]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.